Brokerages Set Quorum Health Corp (QHC) Target Price at $4.00
Quorum Health Corp (NYSE:QHC) has been given an average rating of “Sell” by the seven ratings firms that are currently covering the company, MarketBeat Ratings reports. Four investment analysts have rated the stock with a sell recommendation and three have assigned a hold recommendation to the company. The average 1-year price target among brokerages that have issued a report on the stock in the last year is $4.00.
A number of equities research analysts have commented on QHC shares. ValuEngine raised shares of Quorum Health from a “strong sell” rating to a “sell” rating in a report on Friday, September 1st. Zacks Investment Research raised shares of Quorum Health from a “hold” rating to a “buy” rating and set a $4.75 price objective on the stock in a report on Wednesday, September 13th. Finally, Royal Bank of Canada reissued a “hold” rating and set a $5.00 price objective on shares of Quorum Health in a report on Tuesday, October 3rd.
Shares of Quorum Health (QHC) traded up $0.03 during trading hours on Thursday, reaching $5.03. 764,887 shares of the company’s stock were exchanged, compared to its average volume of 245,030. Quorum Health has a 12-month low of $2.54 and a 12-month high of $9.46. The company has a debt-to-equity ratio of 9.39, a quick ratio of 1.68 and a current ratio of 1.84.
Several hedge funds and other institutional investors have recently modified their holdings of QHC. California Public Employees Retirement System boosted its stake in shares of Quorum Health by 21.9% in the 1st quarter. California Public Employees Retirement System now owns 111,349 shares of the company’s stock valued at $606,000 after purchasing an additional 20,000 shares during the last quarter. Vanguard Group Inc. boosted its stake in shares of Quorum Health by 10.3% in the 1st quarter. Vanguard Group Inc. now owns 1,568,666 shares of the company’s stock valued at $8,534,000 after purchasing an additional 145,904 shares during the last quarter. Geode Capital Management LLC boosted its stake in shares of Quorum Health by 2.6% in the 1st quarter. Geode Capital Management LLC now owns 213,177 shares of the company’s stock valued at $1,159,000 after purchasing an additional 5,373 shares during the last quarter. Dimensional Fund Advisors LP boosted its stake in shares of Quorum Health by 12.9% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,092,288 shares of the company’s stock valued at $5,942,000 after purchasing an additional 124,723 shares during the last quarter. Finally, Renaissance Technologies LLC bought a new position in shares of Quorum Health in the 1st quarter valued at about $459,000. 81.83% of the stock is currently owned by institutional investors.
COPYRIGHT VIOLATION NOTICE: “Brokerages Set Quorum Health Corp (QHC) Target Price at $4.00” was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this report on another site, it was illegally copied and republished in violation of US & international copyright legislation. The correct version of this report can be viewed at https://www.thecerbatgem.com/2017/12/17/brokerages-set-quorum-health-corp-qhc-target-price-at-4-00.html.
About Quorum Health
Quorum Health Corporation is an operator and manager of general acute care hospitals and outpatient services in the United States. The Company operates in two segments: Hospital operations, which includes its general acute care hospitals and related healthcare entities that provide inpatient and outpatient healthcare services, and hospital management advisory and consulting services, which includes Quorum Health Resources, LLC (QHR).
Receive News & Ratings for Quorum Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quorum Health and related companies with MarketBeat.com's FREE daily email newsletter.